PLUS THERAPEUTICS Revenue and Competitors

Austin, TX USA

Location

#6726

Growjo Ranking

Pharma

Industry

Estimated Revenue & Valuation

  • PLUS THERAPEUTICS's estimated annual revenue is currently $2.4M per year.(i)
  • PLUS THERAPEUTICS's estimated revenue per employee is $100,500

Employee Data

  • PLUS THERAPEUTICS has 24 Employees.(i)
  • PLUS THERAPEUTICS grew their employee count by 14% last year.

PLUS THERAPEUTICS's People

NameTitleEmail/Phone
1
President & CEOReveal Email/Phone
2
VP & Chief Financial OfficerReveal Email/Phone
3
VP, Clinical ResearchReveal Email/Phone
4
VP, Corporate Strategy and New Product PlanningReveal Email/Phone
5
VP Clinical OpsReveal Email/Phone
6
VP, Clinical AffairsReveal Email/Phone
7
Assistant Director Quality AssuranceReveal Email/Phone
8
Director, Chemistry,Manufacturing, and ControlsReveal Email/Phone
9
Manager, Drug Development and ProductionReveal Email/Phone
10
ControllerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$26.7M13320%N/AN/A
#2
$13.5M676%N/AN/A
#3
$16.1M80-2%N/AN/A
#4
$62.5M0N/AN/AN/A
#5
$10.1M506%N/AN/A
#6
$119.4M59427%N/AN/A
#7
$22.9M1148%N/AN/A
#8
$92.9M4628%N/AN/A
#9
$11.3M56-8%N/AN/A
#10
$7M356%N/AN/A
Add Company

What Is PLUS THERAPEUTICS?

PLUS THERAPEUTICS (Nasdaq: PSTV) is a U.S. clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat cancers. Our lead drug candidate, Rhenium-186 Nanoliposome, is being evaluated in the NIH-supported multi-center ReSPECT clinical trials for patients with recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancer.

keywords:N/A

N/A

Total Funding

24

Number of Employees

$2.4M

Revenue (est)

14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.7M24-33%N/A
#2
$5.4M2414%N/A
#3
$2.9M24-64%$254M
#4
$1.7M24-37%$4.8M
#5
$2.4M24N/AN/A